COVID updates, around the world: The U.S. says all adults “should” get a booster shot. South Africa’s early Omicron research suggests “mild” s…
The U.S. on Friday opened COVID-19 booster shots to all adults and took the extra step of urging people 50 and older to seek one, aiming to ward off a winter surge as coronavirus cases rise.
Pfizer and Moderna say the FDA has opened up COVID-19 booster shots to all adults, letting them choose another dose of either vaccine. One final step remains.
The Biden administration is making billions of dollars available to drugmakers to scale up domestic production of COVID-19 vaccines in the hop…
WASHINGTON (AP) — Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.
NEW YORK (AP) — An influential U.S. advisory panel will discuss expanding eligibility for COVID-19 vaccine booster shots to all adults Friday, a move that could make the shots available nationwide as early as this weekend.
LONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population.
Pfizer has announced that it will allow its COVID-19 pill to be made and sold cheaply in developing countries.
Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings.
CLAIM: The CEO of Pfizer was arrested on Nov. 5 by FBI agents, charged with fraud and was being held in federal custody while awaiting a bail hearing.
Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections.
Area health care providers are finalizing details about making available the COVID vaccine to children ahead of final approval from federal and state health authorities.
An influential advisory panel on Tuesday recommended kid-size doses of Pfizer's COVID-19 vaccine for children ages 5 to 11, putting the U.S. o…
On Oct. 29, the Food and Drug Administration gave authorization for Pfizer-BioNTech's COVID-19 vaccine for children ages 5 to 11.
Anticipating a green light from vaccine advisers, the Biden administration is assembling and shipping millions of COVID-19 shots for children ages 5-11.
The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week.
A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer's COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.